Production (Stage)
Dynavax Technologies Corporation
DVAX
$10.27
-$0.13-1.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 64.96M | 71.05M | 79.35M | 70.19M | 47.85M |
| Total Other Revenue | 3.21M | 979.00K | 1.29M | 3.61M | 2.95M |
| Total Revenue | 68.16M | 72.03M | 80.63M | 73.80M | 50.79M |
| Cost of Revenue | 32.55M | 31.37M | 26.82M | 26.27M | 23.80M |
| Gross Profit | 35.61M | 40.67M | 53.81M | 47.52M | 26.99M |
| SG&A Expenses | 57.02M | 40.09M | 41.53M | 40.12M | 46.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 89.57M | 71.46M | 68.34M | 66.39M | 70.16M |
| Operating Income | -21.40M | 574.00K | 12.29M | 7.40M | -19.37M |
| Income Before Tax | -97.88M | 7.63M | 19.82M | 14.91M | -11.50M |
| Income Tax Expenses | -1.78M | 579.00K | 2.22M | 3.52M | -2.78M |
| Earnings from Continuing Operations | -96.10M | 7.05M | 17.59M | 11.39M | -8.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -96.10M | 7.05M | 17.59M | 11.39M | -8.72M |
| EBIT | -21.40M | 574.00K | 12.29M | 7.40M | -19.37M |
| EBITDA | -20.23M | 1.76M | 13.47M | 8.54M | -18.25M |
| EPS Basic | -0.77 | 0.06 | 0.13 | 0.09 | -0.07 |
| Normalized Basic EPS | -0.08 | 0.04 | 0.09 | 0.07 | -0.06 |
| EPS Diluted | -0.77 | 0.04 | 0.12 | 0.08 | -0.07 |
| Normalized Diluted EPS | -0.08 | 0.03 | 0.08 | 0.06 | -0.06 |
| Average Basic Shares Outstanding | 124.87M | 127.95M | 131.13M | 130.92M | 130.20M |
| Average Diluted Shares Outstanding | 124.87M | 153.02M | 154.81M | 154.47M | 130.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |